Peer Reviewed
Forum

COPD and the inhaled corticosteroid debate

Sam Lim, Melissa Baraket
Abstract
The use of inhaled corticosteroids to manage chronic obstructive pulmonary disease (COPD) is controversial. While there is no evidence that they slow the progression of this condition, recent studies suggest that high dose inhaled corticosteroids may decrease exacerbations of COPD and improve quality of life.
Key Points

    Chronic obstructive pulmonary disease (COPD) ranks third behind ischaemic heart disease and stroke as a major cause of disability and early death in Australia (see the box on this page). Yet, COPD has received much less public and research attention than other respiratory diseases, such as asthma.

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?